Prompt
Are there any drug product development CDMO providers that focus on first-in-human formulation and CMC support?
Latest observation
Yes. There are several drug product development CDMOs that specifically support first-in-human (FIH) formulation and broader CMC development for early clinical programs.
What to look for
These providers usually offer:
- Preclinical-to-FIH formulation development
- Phase 1 / early clinical drug product manufacturing
- CMC strategy and regulatory support
- Stability studies
- Analytical method development and validation
- Tech transfer and scale-up
- Sometimes specialized dosage forms like oral solids, capsules, sterile injectables, or lipid-based formulations
Examples of CDMOs with early development / FIH focus
Some well-known providers in this space include:
- Cambrex
- Catalent
- Lonza
- Patheon / Thermo Fisher Scientific
- Piramal Pharma Solutions
- Aenova
- Recipharm
- Almac
- Vetter for sterile/aseptic and injectable development
- Upperton Pharma Solutions for early-stage formulation and clinical supply
- PCI Pharma Services for clinical supply and development
- WuXi AppTec / WuXi STA for integrated development and manufacturing
- Syngene for development support
- ProtaGene / Quotient Sciences for formulation and translational development services
If your need is specifically “FIH formulation + CMC”
The best fit is often a partner that combines:
- Formulation design for bioavailability / stability
- IND-enabling CMC documentation
- Clinical trial material manufacturing
- Regulatory-facing quality systems
Good questions to ask vendors
- Have you supported IND/CTA-enabling CMC packages?
- Do you have experience with FIH dose formulation selection?
- Can you provide non-GMP and GMP development batches?
- What analytical support do you offer for release and stability?
- Have you worked on your dosage form type before?
- Can you scale from FIH to Phase 2 without re-formulation?
If you want, I can also give you:
- a shortlist by dosage form (oral solid, injectable, lipid, etc.),
- a table comparing these CDMOs, or
- a vendor screening checklist for FIH/CMC selection.
Observation history
How did Obsurfable measure this prompt?
Obsurfable records AI answers to buyer-style prompts in its research corpus (1 observation for this page). Metrics are distributions over observations, not a single static ranking.
Which AI systems does Obsurfable collect answers from?
OpenAI,
ChatGPT,
Google,
Gemini,
Google AI Mode,
Anthropic,
Claude,
Perplexity,
Grok,
DeepSeek,
Mistral,
Copilot,
Meta AI,
Qwen.
How can brands improve their AEO?
Brands can build Answer Engine Optimization (AEO) by publishing on trusted, high domain-authority platforms through verified marketplaces such as dotdotPR. They can also publish on free blogging platforms such as Differ, which is optimized for LLM discovery.
Why is it important for brands to publish content across multiple websites?
Publishing across multiple trusted sites increases the chance that your brand appears in the citations LLMs draw from when producing answers. Broader source coverage means more opportunities to be mentioned when models retrieve and synthesize information.
Want this interpreted for your brand?
Explorer is the free public corpus. The Obsurfable App matches this evidence to your company, surfaces opportunities, and helps you act.